Silicon Valley has been trying to run a mile from the mess that is Theranos. But the debacle at the blood-testing start-up - which the US Securities and Exchange Commission said this week was a "massive fraud" - will not be as easy to shrug off as the powers-that-be in the tech world would like.
It also holds a particular warning at a time when tech start-ups are extending their reach into industries from healthcare to finance and transportation.
TO READ THE FULL ARTICLE
Thank you for reading The Straits Times
You have reached one of our Premium stories. To continue reading, get access now or log in if you are a subscriber.
What is Premium?